Prof. Dr. med. Mahfoud, Felix
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes
Publikationen
- Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study
- Declining rates of fixed-dose combination pills for hypertension in Germany from 2016 to 2023
- Hidden sodium in effervescent-tablet dietary supplements and over-the- counter drugs: a comparative cross-sectional study
- Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021
- Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia
- Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany
- “Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription
- Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany
- Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide